Arispod-S 1.5 Injection
Marketer
Prosem Healthcare Private Limited
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Arispod-S 1.5 Injection
Combiflox 1.5 Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism prevents microbial proliferation and infection spread. Administration must be solely under a physician's guidance; strict adherence to the prescribed dosage schedule is crucial. Complete the entire course, regardless of symptom improvement; premature cessation may compromise efficacy. Nausea, vomiting, diarrhea, and dyspepsia are potential side effects; worsening symptoms necessitate immediate medical attention. Seek emergency care for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor about concurrent medications, and pregnant or lactating individuals require prior consultation. Alcohol should be avoided due to potential additive drowsiness. While typically non-impairing to driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration promote recovery. Your doctor may order blood tests and other diagnostics to monitor treatment effectiveness.
Uses of Arispod-S 1.5 Injection
Infections caused by bacteria
Major Benefits of Arispod-S 1.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Arispod-S 1.5 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Arispod-S 1.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Arispod-S 1.5 Injection works:
Ceftriaxone and Sulbactam, the components of Arispod-S 1.5 Injection, work synergistically to combat bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial defenses, optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Arispod-S 1.5 Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable formulation Arispod-S 1.5 is typically deemed safe for use in pregnant individuals. Preclinical trials using animal models revealed minimal or no negative consequences for fetal development; however, clinical data from human studies remain scarce.
Breast feedingCAUTION
The administration of Arispod-S 1.5 Injection to breastfeeding mothers requires careful consideration. It is recommended to discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from the maternal system.
DrivingUNSAFE
Administration of Arispod-S 1.5 Injection may induce drowsiness, visual disturbances, or dizziness. Driving should be avoided if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Arispod-S 1.5 Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable formulation Arispod-S 1.5 requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Arispod-S 1.5 Injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Arispod-S 1.5 Injection :
Omit a dose of Arispod-S 1.5 Injection? Seek medical advice immediately.
Facts to Know About Arispod-S 1.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently